Bihari L Gupta*

Department of Zoology, J.K. College, Biraul, Darbhanga, Bihar, India

*Corresponding Author: Bihari L Gupta, Department of Zoology, J.K. College, Biraul, Darbhanga, Bihar, India.

Received: August 13, 2021; Published: August 30, 2021

Citation: Bihari L Gupta. “Lavender (Lavandula latifolia) Explicits High Efficiency in Old Aged Chronic Piles Patient". Acta Scientific Gastrointestinal Disorders 4.9 (2021): 70-72.

Abstract

  Lavender (Lavender latifolia) was given to a dying 86 years old woman who had been suffering from piles for the last 45 years with an emerged fistula of more than 6 inches which used to bleed daily. She stopped taking drugs prescribed by physician as they were not performing effects due to resistance to drugs. In such a situation the patient was feeling severe pain in stomach and more bleeding in stools. The alternative treatment was performed by an oral intake of 5 drops of lavender in 5 ml of water three times a day along with a teaspoonful of each of Diegene, Liv-52 (Himalaya) and multiple vitamins syrup. About 18 gms of proteins in the form of Horlicks was also given to the patient. After 10 days of treatments the patient condition became stable resulting in complete stoppage of blood in the stools and also relieved from the stomach pain.

It was also observed the patient recognized every person of the family confirming a best function of gut-brain axis which is disturbed by specific overgrowth of bacteria.

In conclusion it may be proved that lavender kills the microbes in the gut, relieves from pain and maintains a good homeostasis between gut and brain. It may be a potential alternative in treating piles even in chronic condition.

Keywords: Piles; Lavender

Bibliography

1. Pifer R and Sperandio V. “The Interplay between the Microbiota and Enterohemorrhagic Escherichia coli”. Microbiology Spectrum5 (2014): 1-5.
2. Bienenstock J., et al. “Microbiota and the gut-brain axis”. Nutrition Review 73 (2015): 28-31.
3. LeClere FB., et al. “Prevalence of major digestive disorders and bowel symptoms”. Advance Data 24 (1992): 1-15.
4. Becker de Moura H and Ribeiro-Silva A. “Death resulting from fournier gangrene secondary to thrombosis of very large hemorrhoids: report of a case”. Diseases of the Colon and Rectum10 (2007): 1715-1718.
5. Forbes JD. “A Fungal World: Could the Gut Mycobiome be involved in neurological disease?” Forntiers in Microbiology 9 (2018): 1-11.
6. Cui L. “The human mycobiome in health and disease”. Genome Medicine 7 (2013): 63.
7. Hanamanthagouda MS., et al. “Essential oils of Lavandula bipinnata and their antimicrobial activities”. Food Chemistry 118 (2010): 836-839.
8. Gupta BL., et al. “Effect of experimental diabetes on the activities of hexokinase, glucose-6-phosphate dehydrogenase and catecholamines in rat erythrocytes of different ages”. Indian Journal of Experimental Biology 35 (1997): 792-795.
9. Hand TW., et al. “Linking the microbiota, chronic disease, and the immune system”. Trends in Endocrinology and Metabolism 27 (2016): 831-843.
10. Baumler A and Sperandio V. “Interactions between the microbiota and the pathogenic bacteria in the gut”. Nature 535 (2016): 85-93.
11. Findley K., et al. “Topographic diversity of fungal and bacterial communities in human skin”. Nature7454 (2013): 367-370.

Copyright: © Bihari L Gupta. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.